Endoscopic Endonasal Skull Base Surgery for Giant Pituitary Adenomas: 60-Patient Case Series
Journal of Neurological Surgery Part B: Skull Base · 01.02.2023 · 84 (S 01 S 01) · S1-S344
DOI: 10.1055/s-0043-1762003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.02.2023. Verfasst von Agustin Dorantes-Argandar und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Objectives
Treatment of giant pituitary adenomas represents a formidable surgical challenge due to size, shape, invasiveness, and perioperative morbidity. We present our case series results for the endoscopic endonasal surgical treatment of this disease.
Background
Giant pituitary adenomas (>40 mm maximum diameter) represent among 5 to 14% of all pituitary adenomas and most surgical series report an average of 50% gross total resection rate.
Methods
Descriptive statistical analysis of demographic data, clinical presentation, tumor characteristics, and surgical results of 60 patients with giant pituitary adenomas treated solely by endoscopic endonasal skull base surgery by one surgeon.
Results
In our series, giant pituitary adenomas were more frequent in women (54.8%), mean age of presentation was 45.5 years, mean tumor maximum diameter was 49.5 mm, and the most frequent tumor subtype was non-secreting pituitary adenoma (85.7%). Most tumors had an oval configuration (59.5%), some had an hourglass configuration (19%), and others were multilobular in shape (21.4%). Principal tumor location was at the sellar and suprasellar region (71.4%), principal tumor extension was to the third and lateral ventricles (28.6%), and cavernous sinus invasion was present in 71.4%. We obtained a gross total resection in 71.4%, near total resection in 9.5%, and partial resection in 19%. Biochemical remission for secreting giant pituitary adenomas was 33.34%. Postoperative visual status was improved in 95.2%, unchanged in 2.4%, and worse in 2.4%. During follow-up (mean: 40.62 months), 41.66% of the non-secreting tumor residuals had tumor progression and 66.66% of all secreting tumors had biochemical persistence. Our overall perioperative complication rate was 11.6%. We had patients with postsurgical CSF fistula (5%), postsurgical epistaxis (3.3%), permanent diabetes insipidus (1.6%), postsurgical intracranial hemorrhage (1.6%), postsurgical blindness (1.6%), postsurgical massive pulmonary embolism (1.6%), and no mortality.
Conclusion
The surgical treatment for giant pituitary adenomas is difficult to standardize and every case represents unique challenges. Multilobular tumor configuration and high-grade cavernous sinus invasion are our current surgical limitations for gross total resection and biochemical remission. Initial surgical treatment of this disease should be focused to obtain maximum safe surgical resection with the best optic apparatus decompression possible. Publication History Article published online: 01 February 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Dorantes-Argandar, A., Rodas-Berrezueta, F., Perez-Garcia, L., Mancilla-Mejia, J., Lopez-Quintana, B., & Garcia-Guzman, B. (2023). Endoscopic Endonasal Skull Base Surgery for Giant Pituitary Adenomas: 60-Patient Case Series. Journal of Neurological Surgery Part B: Skull Base, 84(S 01 S 01), S1-S344. https://doi.org/10.1055/s-0043-1762003
Vancouver
Dorantes-Argandar A, Rodas-Berrezueta F, Perez-Garcia L, Mancilla-Mejia J, Lopez-Quintana B, Garcia-Guzman B. Endoscopic Endonasal Skull Base Surgery for Giant Pituitary Adenomas: 60-Patient Case Series. Journal of Neurological Surgery Part B: Skull Base. 2023;84(S 01 S 01):S1-S344. doi:10.1055/s-0043-1762003
BibTeX
@article{DorantesArgandar2023,
author = {Dorantes-Argandar, Agustin and Rodas-Berrezueta, Flavio and Perez-Garcia, Luis and Mancilla-Mejia, Javier and Lopez-Quintana, Brenda and Garcia-Guzman, Berenice},
title = {Endoscopic Endonasal Skull Base Surgery for Giant Pituitary Adenomas: 60-Patient Case Series},
journal = {Journal of Neurological Surgery Part B: Skull Base},
year = {2023},
volume = {84},
number = {S 01 S 01},
pages = {S1--S344},
doi = {10.1055/s-0043-1762003}
}
EUVIMED